Novira Therapeutics was a biopharmaceutical company developing direct-acting antivirals for chronic hepatitis B (HBV), notably HBV capsid assembly modulators. It was acquired by Johnson & Johnson (Janssen) in 2015 and no longer operates as an independent entity. - View it on GitHub